retatrutide trial results today Rachel the Dietitian_ Redefining Menopause for Our Generation | Eli Lilly announced promising Phase 3 for retatrutide, a next-generation obesity medication targeting THREE metabolic Triple hormone receptor agonist retatrutide

Why Mate Tea

ActivAmp Gynostemma Pentaphyllum Leaf Extract: Acts as a metabolic master switch, signaling the body to burn fat for energy rather than storing it

Find relief from GLP-1 nausea with these practical insights

This systematic review and meta-analysis aims to update the evidence on the impact of GLP-1 RAs on EGD outcomes, evaluate the effect of concurrent colonoscopy (CLN) on GRC, and assess the influence of different GLP-1 RA agents on GRC

The expansion of GLP-1 drug efficacy evidence in 2024, a concise review by Daniel Drucker, a pioneer of the field | 28 comments on LinkedIn

This specialized delivery system helps shield the active berberine molecules through the stomach, supporting up to 10X greater cellular uptake while remaining gentle on your digestive system